Aditxt (ADTX) is trading up at $0.00 (0.00%), as of the latest quote. It operates in the Health Care sector.
| FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | — | — | $105.0K | $933.7K | $645.2K | $134.0K | $3.19K |
| Growth (year over year) | — | — | — | +789.0% | −30.9% | −79.2% | −97.6% |
| Gross profit | — | — | $27.1K | $166.9K | −$111.7K | −$493.5K | $268 |
| Gross margin | — | — | 25.8% | 17.9% | −17.3% | −368.3% | 8.4% |
| Operating income | −$5.87M | −$8.87M | −$41.9M | −$25.5M | −$26.1M | −$27.9M | −$19.6M |
| Operating margin | — | — | −39925.1% | −2728.9% | −4039.6% | −20796.1% | −612542.2% |
| Net income | −$5.83M | −$9.15M | −$46.4M | −$27.6M | −$32.7M | −$40.4M | −$43.1M |
| Net margin | — | — | −44148.9% | −2961.3% | −5068.5% | −30117.9% | −1349028.2% |
| EPS (diluted) | −$6080000.00 | −$5320000.00 | −$242360.00 | −$595.60 | −$27038.26 | −$22147415.22 | −$1153.83 |
| Balance sheet | |||||||
| Cash and equivalents | $4.09K | $10.5M | $7.87M | $2.77M | $97.1K | $833.0K | $3.20M |
| Total assets | $123.5K | $13.1M | $16.7M | $10.7M | $44.6M | $32.1M | $16.5M |
| Total liabilities | $2.98M | $2.09M | $6.48M | $5.53M | $28.5M | $23.9M | $12.6M |
| Shareholders' equity | −$2.85M | $11.0M | $10.2M | $5.21M | $16.1M | $1.67M | $5.61M |
| Cash flow | |||||||
| Operating cash flow | −$464.4K | −$7.22M | −$22.3M | −$22.4M | −$19.2M | −$16.8M | −$25.7M |
| Capital expenditure | — | — | — | $367.1K | $14.4K | — | $13.7K |
| Free cash flow | — | — | — | −$22.8M | −$19.2M | — | −$25.7M |
| Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $44.3K | $6.85K | — | $1.02K | $1.00K | $748 | $425 | $12.2K |
| Growth (year over year) | −80.0% | −94.5% | — | −98.7% | −97.7% | −89.1% | — | +1094.4% |
| Gross profit | $21.1K | −$460.7K | — | $284 | −$1 | $16 | −$31 | $2.87K |
| Gross margin | 47.8% | −6721.4% | — | 27.9% | −0.1% | 2.1% | −7.3% | 23.6% |
| Operating income | −$5.98M | −$4.70M | — | −$5.61M | −$6.15M | −$3.14M | −$4.67M | −$4.36M |
| Operating margin | −13497.1% | −68588.2% | — | −550895.4% | −612788.3% | −419870.3% | −1098725.6% | −35873.5% |
| Net income | −$7.55M | −$12.8M | — | −$5.71M | −$7.26M | −$24.0M | −$6.09M | −$15.9M |
| Net margin | −17051.3% | −187445.6% | — | −560934.1% | −722789.6% | −3214626.3% | −1432689.2% | −131159.8% |
| EPS (diluted) | −$1047.17 | −$3137695.20 | — | −$198072.98 | −$3.45 | −$548.78 | $197471.38 | −$790.49 |
| Balance sheet | ||||||||
| Cash and equivalents | $91.2K | $328.6K | $833.0K | $476.4K | $323.7K | $163.0K | $3.20M | $268.9K |
| Total assets | $28.4M | $29.8M | $32.1M | $31.2M | $32.7M | $11.8M | $16.5M | $13.9M |
| Total liabilities | $22.0M | $25.4M | $23.9M | $15.5M | $20.7M | $20.7M | $12.6M | $49.1M |
| Shareholders' equity | $6.57M | $4.71M | $1.67M | $16.6M | $13.0M | −$7.73M | $5.61M | −$33.3M |
| Cash flow | ||||||||
| Operating cash flow | −$2.29M | −$2.36M | — | −$11.7M | −$2.38M | −$2.34M | −$9.25M | −$4.58M |
| Capital expenditure | — | — | — | — | — | — | — | $10.4K |
| Free cash flow | — | — | — | — | — | — | — | −$4.59M |
From Aditxt's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Aditxt in our feed yet.